1. Home
  2. FTCI vs CUE Comparison

FTCI vs CUE Comparison

Compare FTCI & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTC Solar Inc.

FTCI

FTC Solar Inc.

HOLD

Current Price

$3.85

Market Cap

122.4M

Sector

Technology

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$31.26

Market Cap

124.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTCI
CUE
Founded
2017
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.4M
124.5M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
FTCI
CUE
Price
$3.85
$31.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$10.80
$120.00
AVG Volume (30 Days)
106.5K
115.0K
Earning Date
05-01-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.11
EPS
N/A
N/A
Revenue
$99,687,000.00
$27,466,000.00
Revenue This Year
$65.44
N/A
Revenue Next Year
$45.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
110.51
195.75
52 Week Low
$3.21
$0.17
52 Week High
$12.75
$45.50

Technical Indicators

Market Signals
Indicator
FTCI
CUE
Relative Strength Index (RSI) 32.71 53.29
Support Level $3.30 $23.88
Resistance Level $5.40 $32.82
Average True Range (ATR) 0.41 4.68
MACD -0.12 -0.52
Stochastic Oscillator 6.70 26.82

Price Performance

Historical Comparison
FTCI
CUE

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: